Showing results (291-300 of 304) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignanciesRanjana H Advani, Joseph J Buggy, Jeff P Sharman, et al.
Molecular Cancer Therapeutics|August 8, 2006
CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivoZ Alexander Cao, Kathryn E Bass, Sriram Balasubramanian, et al.
Npj Drug Discovery|July 1, 2026
Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunityLih-Yun Hsu, James T Rosenbaum, Erik Verner, et al.
Journal of Opioid Management|October 29, 2021
Multimodal opioid sparing onco-anesthesia: A consensus practice guideline from Society of Onco-Anesthesia and Perioperative Care (SOAPC)Sohan Lal Solanki, Raghu S Thota, Jeson Rajan, et al.
Cancer Cell|June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphomaYibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Structure (London, England : 1993)|July 10, 2004
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylasesJohn R Somoza, Robert J Skene, Bradley A Katz, et al.
Pageof 31